corticosterone has been researched along with Tumor Lysis Syndrome in 1 studies
Tumor Lysis Syndrome: A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Interleukin-2 has been tested as an anti-cancer agent, either alone or in combination with immune cells, but severe dose limiting adverse toxic effects have been observed." | 1.28 | Interleukin-2 induced systemic toxicity: induction of mediators and immunopharmacologic intervention. ( Bendele, AM; Butler, LD; Cain, RL; Layman, NK; Mohler, KM; Puckett, LD; Riedl, PE, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, LD | 1 |
| Mohler, KM | 1 |
| Layman, NK | 1 |
| Cain, RL | 1 |
| Riedl, PE | 1 |
| Puckett, LD | 1 |
| Bendele, AM | 1 |
1 other study available for corticosterone and Tumor Lysis Syndrome
| Article | Year |
|---|---|
Interleukin-2 induced systemic toxicity: induction of mediators and immunopharmacologic intervention.
Topics: Adrenal Glands; Animals; Antineoplastic Agents; Antiviral Agents; Biological Factors; Cell Division; | 1989 |